HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of FX dialysers on systemic inflammation and quality of life in chronic haemodialysis patients.

AbstractBACKGROUND:
The FX class of haemodialysers features a new class of high-flux polysulfone membrane which has been suggested to induce less inflammation.
METHODS:
This was a randomized, cross-over study performed on 33 haemodialysis patients. Patients were randomized to FX60 or HF80 dialysers for 3 months and then changed to the other dialyser. Interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) were measured at baseline, and every 3 months. The Kidney Disease Quality of Life Short Form was also administered.
RESULTS:
The mean of the difference in the IL-6 level between dialysers was 1.4 +/- 8.0 pg/ml (95% CI -1.8, 4.5 pg/ml). There was no significant difference in TNF-alpha (95% CI -0.35, 0.18 pg/ml) or CRP levels (95% CI -2.67, 6.20 mg/l). The quality of social interaction and role limitations caused by physical health problems were significantly higher with the FX60, p = 0.04 and 0.047, respectively.
CONCLUSIONS:
The FX dialysers do not result in a significant difference in the level of systemic inflammation compared to the HF80.
AuthorsNeil Boudville, Marilyn Horner, Elizabeth McEwan, Wai H Lim, David W Mudge, Hadley E Markus
JournalBlood purification (Blood Purif) Vol. 27 Issue 2 Pg. 187-93 ( 2009) ISSN: 1421-9735 [Electronic] Switzerland
PMID19141998 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Erythropoietin
  • Darbepoetin alfa
  • Epoetin Alfa
  • C-Reactive Protein
Topics
  • Adult
  • Aged
  • C-Reactive Protein (metabolism)
  • Cross-Over Studies
  • Darbepoetin alfa
  • Epoetin Alfa
  • Erythropoietin (administration & dosage, analogs & derivatives)
  • Female
  • Humans
  • Inflammation (drug therapy)
  • Interleukin-6 (metabolism)
  • Male
  • Middle Aged
  • Quality of Life (psychology)
  • Recombinant Proteins
  • Renal Dialysis (instrumentation, psychology)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: